The reframe that changes everything
Ask "how do I remove plaque from my arteries?" and the internet will sell you cleanses, enzymes, and "artery-flushing" protocols. The premise is wrong. Arterial plaque isn't gunk in a pipe that you can scrub or dissolve out. It's a structural change in the artery wall built over years.
And here's why even "modest" matters enormously: reducing plaque burden by as little as 1% has been associated with roughly a 25% lower risk of heart attack and stroke. So the unglamorous, single-digit numbers you'll see below are not disappointing — they're the whole game.
What plaque actually is
A quick, honest picture of the biology, because the rest only makes sense once you have it. Your arteries are lined by a delicate single-cell layer called the endothelium. Atherosclerosis begins when LDL cholesterol particles slip into the artery wall beneath that lining and get trapped, especially where the endothelium is already stressed by high blood pressure, smoking, or high blood sugar.
Once inside the wall, LDL becomes oxidized and triggers an inflammatory response: immune cells move in, gorge on the cholesterol, and become foam cells. Over years this builds a plaque — a mound of cholesterol, dead cells, and debris within the wall, capped by a layer of fibrous tissue. So plaque is fundamentally a cholesterol-plus-inflammation problem inside the wall, not a coating on the inside surface. That single fact is why "scrubbing" is the wrong mental model, and why the things that work target cholesterol and inflammation rather than trying to physically clear a channel.
The heart attack usually doesn't come from the artery slowly narrowing to a close. It comes when a plaque's fibrous cap ruptures, exposing its contents and triggering a sudden clot. That's why stability matters more than size — and it's the key to everything below.
Soft vs. calcified plaque (most people have this backwards)
Not all plaque is equally dangerous, and the intuition that "hard, calcified plaque sounds worse" is exactly wrong.
Soft (non-calcified) plaque
- Lipid-rich, inflamed, with a thin fibrous cap.
- More likely to rupture and trigger the clot that causes a heart attack or stroke.
- The most responsive to aggressive cholesterol-lowering — this is the part you can actually shrink.
Calcified plaque
- Hardened with calcium; a sign of older, "healed" disease.
- More stable, less likely to rupture — but still marks artery damage and overall risk.
- Cannot meaningfully be "reversed" — calcium doesn't un-deposit.
The counterintuitive consequence: treatment often works partly by turning dangerous soft plaque into stable, more calcified plaque. So a calcium score that rises a bit on treatment can sometimes mean soft plaque is being stabilized — progress, not failure. (Interpreting that is a job for your doctor, not a home calculation.)
What actually works — ranked by evidence
Here are the real levers for stabilizing and regressing plaque, tiered by how strong the evidence is. Notice the pattern: the best-proven interventions are the least glamorous.
The single best-proven lever, full stop. Across imaging trials, plaque regression is consistently achieved once LDL is driven low — below about 80 mg/dL, and most dramatically lower. The landmark ASTEROID trial showed real regression with high-intensity statin therapy at an LDL around 53–60 mg/dL; the cardiologist who ran it has noted regression of up to ~24% when LDL drops below 70. The theme across trials: high-intensity statins beat low-intensity ones for plaque, and lower LDL is better. For most people who already have plaque, reaching these levels needs medication, not diet alone.
For those who need lower LDL than a statin alone delivers, injectable PCSK9 inhibitors add further regression on top (the GLAGOV trial showed additional plaque-volume reduction vs. placebo). Ezetimibe and bempedoic acid are other add-ons. These are prescription tools, used under cardiology guidance — but the evidence that driving LDL very low shrinks soft plaque is robust.
Plaque is an inflammatory process, not just a cholesterol one. A drop in the inflammatory marker CRP independently predicts regression in statin trials, and anti-inflammatory drugs like low-dose colchicine are now being studied specifically for plaque stability. Promising, and a real part of the picture — though still developing compared with LDL-lowering.
Real, but a foundation rather than a standalone cure. The intensive Ornish program (very-low-fat, plant-based, plus exercise and stress management) produced modest plaque regression over a year and at five years, while controls progressed — but it's extremely strict and hard to sustain. Modern imaging trials find plant-forward diets shift plaque toward the safer, less rupture-prone type even when total volume barely moves, and Mediterranean-pattern diets slow progression. The durable theme: less saturated fat, more fiber-rich plants. See the diets guide and food guide.
Powerful for outcomes, smaller for plaque volume directly. Exercise mainly improves endothelial function and circulation and cuts cardiovascular mortality substantially; its direct plaque-shrinking effect is more modest than statins, though high-intensity interval training has shown beneficial plaque effects in trials. Combined with LDL-lowering, far better than either alone. (More in the performance guide.)
Not smoking, controlling blood pressure, and managing blood sugar are foundational — each protects the endothelium and slows the whole process. Unglamorous, free or cheap, and among the highest-impact things anyone can do for their arteries.
Supplements, honestly tiered
This is where the marketing is loudest and the evidence is thinnest. A few have a real (if modest) signal; most don't earn their claims. None has been shown to "clean" arteries.
The one with the most legitimacy — because it naturally contains monacolin K, which is chemically identical to the statin lovastatin. It genuinely lowers LDL. But that's the catch: it's an unregulated statin in disguise, with wildly variable potency between brands and the same potential side effects (and contamination concerns). If it works, it works because it's a drug; many cardiologists would rather prescribe a known, dosed statin. Not a "natural alternative" so much as an unstandardized one.
Often taken alongside statins to ease muscle side effects (evidence there is mixed). For plaque itself, there's no convincing evidence it regresses or removes it. Generally safe; just don't expect it to clear arteries.
This one gets marketed hardest as an "artery cleaner," and the evidence is genuinely conflicting — enough that it's worth walking through as a worked example of how to read this kind of claim. See the next section.
The honest hierarchy: even the best supplement here (red yeast rice) is, at best, a less-predictable version of a statin. No supplement has been shown to remove established plaque, and none comes close to the evidence behind LDL-lowering. Our supplement guide tiers these individually.
Nattokinase: a case study in not getting fooled
Nattokinase (an enzyme from fermented soybeans) is sold widely as something that dissolves plaque and "cleans" arteries. It's the perfect teaching case, because the human studies genuinely point in opposite directions — and which ones you're shown determines what you'll believe.
See the pattern? The biggest, most exciting results come from the weakest study designs; the most rigorous study found nothing. That's the opposite of what you want before believing a claim. Nattokinase does have a real clot-dissolving (fibrinolytic) action — but that's different from reversing wall plaque, no trial has tested it for actual heart attacks or strokes, and the commonly repeated "it downregulates the cholesterol enzyme like a statin" claim isn't supported (the head-to-head trial found it lowered cholesterol less than the statin).
Verdict: contested, leaning unproven — more signal than nothing, but well short of the strong evidence behind LDL-lowering. And a real safety note: nattokinase thins the blood, so combined with aspirin or anticoagulants it carries genuine bleeding risk. It's a "talk to your doctor first," not a casual addition.
How plaque is measured: the CAC score
If you actually want to know what's in your arteries, the most useful everyday test is a coronary artery calcium (CAC) scan — a quick, low-radiation CT that scores your calcified plaque burden (the Agatston score). It's a strong, well-validated predictor of cardiovascular risk that often reclassifies people beyond what standard risk calculators show.
| CAC score | What it broadly suggests |
|---|---|
| 0 | The "power of zero" — very low near-term risk; may support deferring or de-escalating medication in the absence of other strong risk factors. |
| 1–99 | Subclinical atherosclerosis present; individualized decision, statin often considered (especially with age/risk factors). |
| 100–399 | Meaningful burden; generally supports initiating/intensifying statin and tightening blood pressure and glucose control. |
| 400–999 | High risk; intensive risk-factor control warranted. |
| ≥1,000 | A distinct very-high-risk group; aggressive LDL-lowering and added therapies (e.g. ezetimibe/PCSK9) often considered. |
An important subtlety that ties back to soft-vs-calcified: CAC measures calcified plaque, so it can miss early soft plaque, and — as noted above — a score can rise as soft plaque stabilizes into calcium. It's a powerful risk and tracking tool, but it's interpreted in context by a clinician, alongside your bloodwork (LDL, ApoB, Lp(a)) and overall picture. Carotid ultrasound (CIMT) is another, different way to look at the arteries in the neck.
The "cleanse" myths
No product mechanically clears or dissolves established wall plaque. Plaque lives in the artery wall, built from cholesterol and inflammation — it's not surface gunk. The real levers stabilize and modestly shrink it over months to years; nothing "flushes" it.
The big NIH trial (TACT) found EDTA chelation produced only a modest reduction in events, concentrated in people with diabetes — and the follow-up TACT2 failed to confirm even that. It's not FDA-approved for heart disease, carries real risks, and is not a routine treatment. Not the artery-cleaner it's sold as.
Partly. Intensive diet-and-lifestyle programs can produce modest regression and clearly cut events — a real, worthwhile effect. But the degree of LDL-lowering that drives meaningful regression usually can't be reached by diet alone once plaque is established, which is why most cardiologists pair lifestyle with medication rather than betting on diet by itself.
Not necessarily. Because stabilizing soft plaque can increase its calcification, calcium scores can rise even as arteries become safer. This is why scores are interpreted by a clinician in context, not read as a simple "more = worse" gauge.
The honest limits
Frequently asked
Can you actually remove plaque from your arteries?
What's the single most effective thing I can do?
Does nattokinase clean out arteries?
Is a calcium (CAC) scan worth getting?
Can diet alone reverse my plaque?
Why does my calcium score go up even though I'm treating it?
Sources & further reading
This guide is educational and not medical advice. Atherosclerosis is a serious medical condition. Decisions about statins, other medications, supplements, testing, and targets should be made with a qualified clinician who knows your history — especially regarding LDL goals, any supplement with bleeding risk, and the interpretation of any imaging. Do not start, stop, or change treatment based on this page alone.